What Is Tyrocidine? Definition and What Research Reports

Tyrocidine is the collective name for a family of cyclic decapeptides — ring-shaped peptides built from ten amino acid residues — produced by the soil bacterium Bacillus aneurinolyticus and isolated historically as part of the tyrothricin peptide complex. Individual members are usually labelled tyrocidine A, B, C and their analogues, and they differ from one another mainly in which aromatic amino acids occupy a small number of positions in the ring. Because the peptides are assembled by bacterial non-ribosomal peptide synthetase machinery rather than by ribosomal translation, natural preparations are mixtures of closely related congeners rather than a single uniform molecule. In the peptide literature tyrocidine is classified as a membrane-active antimicrobial peptide, and the great majority of published work on it is laboratory work — microbiology, biophysics and materials science — rather than clinical research.

This page is for educational purposes only and is not medical advice; consult a licensed physician for questions about any compound, medical condition or treatment decision. Nothing here describes how tyrocidine should be used, and the entry is intended as a reference definition of the term as it appears in published research.

Molecular class and origin

Tyrocidines belong to the broad class of cationic cyclic antimicrobial peptides. Several features recur in descriptions of the family:

• Cyclic backbone. The ten residues are joined head-to-tail, so there is no free N-terminus or C-terminus — a structural difference from linear research peptides such as the growth-factor or secretagogue fragments more commonly discussed in peptide glossaries.
• Aromatic and cationic residues. The ring contains aromatic residues (phenylalanine, tryptophan, tyrosine) alongside basic residues, which is the combination generally associated with peptide–membrane interaction.
• Bacterial origin. The producing organism is Bacillus aneurinolyticus, and tyrocidines were described as cyclic antimicrobial peptides isolated from that species in a study of agronomically relevant fungal phytopathogens (PMID 24996824).
• Natural variability. Researchers modelled the variable incorporation of aromatic amino acids in the tyrocidines and analogous cyclodecapeptides, describing how the producing system generates a spread of related congeners rather than one sequence (PMID 31461193).

Tyrocidine versus tyrothricin

The two terms are often confused. Tyrothricin is the historical name of the crude peptide complex obtained from the bacterium; tyrocidine refers to the cyclic decapeptide fraction within that complex. Papers that study purified peptides therefore speak of "the tyrocidines" in the plural, reflecting the mixture of congeners described in the structural modelling literature (PMID 31461193).

How the term is used in peptide research

Tyrocidine is not used in the literature as a metabolic, cosmetic or regenerative research peptide. It appears in four recurring contexts:

1. Antimicrobial microbiology. As a reference membrane-active peptide tested against fungi, yeasts and bacteria in vitro.
2. Structure–activity relationship (SAR) work. As a scaffold whose ring composition can be varied systematically, which researchers used in a detailed SAR and principal component analysis of tyrocidines and analogues against leucocin A-sensitive and leucocin A-resistant Listeria monocytogenes (PMID 24766734).
3. Peptide biophysics. As a model for β-sheet folding and self-association; a 2013 study reported β-sheet structures and dimer models for the two major tyrocidines (PMID 24151934).
4. Formulation and materials science. As an active component investigated in surfaces and carriers, including work on creating robust antimicrobial materials with "sticky" tyrocidines (PMID 35203778).

What the Published Literature Reports

The verified papers summarised below are laboratory investigations. They describe activity in cultured organisms, on materials or in structural models — not outcomes in humans.

Antifungal and anti-yeast work

One study reported inhibition of agronomically relevant fungal phytopathogens by tyrocidines, the cyclic antimicrobial peptides isolated from Bacillus aneurinolyticus (PMID 24996824). A later paper examined antifungal membranolytic activity of the tyrocidines against filamentous plant fungi, framing the mechanism as disruption of the fungal membrane (PMID 27328781). Separately, researchers reported that cellulose-type formulants influenced the anti-Candida activity of the tyrocidines, meaning that the carrier material itself altered what was measured in the assay (PMID 34069885).

Antibacterial and structural work

The SAR and principal component analysis study compared tyrocidines and analogues against leucocin A-sensitive and leucocin A-resistant Listeria monocytogenes, relating peptide composition to observed antibacterial profiles (PMID 24766734). Biophysical work reported β-sheet structures and dimer models for the two major tyrocidines, supporting the view that these peptides associate rather than acting purely as isolated monomers (PMID 24151934).

Derivatives and materials

A 2022 paper described a novel antiamoebic tyrocidine-derived peptide investigated against brain-eating amoebae, illustrating how the scaffold has been modified to explore targets beyond fungi and bacteria (PMID 36033708). Another 2022 study reported the use of the peptides' adhesive ("sticky") behaviour in creating robust antimicrobial materials (PMID 35203778).

Safety and Tolerability: What Studies Report

The verified papers listed on this page are in vitro microbiology, structural and materials studies; they report on organisms, peptide conformation and formulated surfaces rather than on human dosing, systemic exposure or adverse events. For that reason no human safety profile, dose range or tolerability data is stated here — the cited record does not contain it. Statements circulating outside the peer-reviewed literature about systemic use of tyrocidine are not supported by the studies summarised above, and membrane-active peptides in general are typically evaluated for selectivity between microbial and host membranes before any application is considered.

Limits of the current evidence

• Mixtures, not single molecules. Because aromatic residue incorporation varies, "tyrocidine" in one paper may not be compositionally identical to "tyrocidine" in another (PMID 31461193).
• Context dependence. Researchers reported that the surrounding formulation material changed measured anti-Candida activity, so assay conditions matter when comparing results (PMID 34069885).
• Self-association. Dimer and β-sheet models indicate the active species may be an assembly rather than a monomer, complicating simple potency comparisons (PMID 24151934).
• No clinical trial data in this set. None of the verified papers reported controlled human outcomes.

Related glossary terms

• Cyclodecapeptide — a cyclic peptide of ten residues; the structural class to which tyrocidines belong (PMID 31461193).
• Membranolytic peptide — a peptide whose antimicrobial mechanism involves disrupting target membranes, as described for tyrocidines against filamentous fungi (PMID 27328781).
• Structure–activity relationship (SAR) — systematic comparison of sequence variants against a biological endpoint, as applied to tyrocidine analogues and Listeria monocytogenes (PMID 24766734).

References

• Creating Robust Antimicrobial Materials with Sticky Tyrocidines (Antibiotics (Basel), 2022)
• The Influence of Cellulose-Type Formulants on Anti-Candida Activity of the Tyrocidines (Antibiotics (Basel), 2021)
• Modelling the variable incorporation of aromatic amino acids in the tyrocidines and analogous cyclodecapeptides (Journal of Applied Microbiology, 2019)
• Antifungal membranolytic activity of the tyrocidines against filamentous plant fungi (Biochimie, 2016)
• Inhibition of agronomically relevant fungal phytopathogens by tyrocidines, cyclic antimicrobial peptides isolated from Bacillus aneurinolyticus (Microbiology, 2014)
• Detailed SAR and PCA of the tyrocidines and analogues towards leucocin A-sensitive and leucocin A-resistant Listeria monocytogenes (Chemical Biology & Drug Design, 2014)
• β-sheet structures and dimer models of the two major tyrocidines, antimicrobial peptides from Bacillus aneurinolyticus (Biochemistry, 2013)
• Novel Antiamoebic Tyrocidine-Derived Peptide against Brain-Eating Amoebae (ACS Omega, 2022)